Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.71 |
| ▸ | DRD4 | P21917 | 1/20 | 0.71 |
| ▸ | DRD3 | P35462 | 1/20 | 0.71 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.55 |
| ▸ | CTSS | P25774 | 14/20 | 0.48 |
| ▸ | MC4R | P32245 | 1/20 | 0.47 |
| ▸ | CHKA | P35790 | 1/20 | 0.46 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8964019 | 0.89 | DRD2 (0.71) | DRD2DRD4DRD3CTSSMC4R | |
| Hydrochloric Acid SCHEMBL10644520 | 0.88 | DRD2 (0.56) | DRD2DRD4DRD3GRIN2BCTSS | |
| SCHEMBL8963668 | 0.83 | DRD2 (0.64) | DRD2DRD4DRD3CTSS | |
| SCHEMBL8834289 | 0.83 | DRD4 (1.00) | DRD2DRD4DRD3CTSS | |
| SCHEMBL8963868 | 0.83 | DRD2 (0.63) | DRD2DRD4DRD3CTSS | |
| SCHEMBL9720664 | 0.82 | DRD2 (0.62) | DRD2DRD4DRD3CTSS | |
| Hydrochloric Acid SCHEMBL8963938 | 0.81 | DRD2 (0.58) | DRD2DRD4DRD3GRIN2BCTSS | |
| SCHEMBL9725056 | 0.81 | DRD4 (0.67) | DRD2DRD4DRD3CTSS | |
| SCHEMBL6861390 | 0.80 | DRD2 (0.60) | DRD2DRD4DRD3GRIN2BCTSS | |
| SCHEMBL8963974 | 0.80 | DRD3 (0.59) | DRD2DRD4DRD3CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5514800-A | CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA | SYNTEX PHARMACEUTICALS, LTD. (GB) | 1996-05-07 | — | — | US | disclosed |
| US-5276034-A | Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents | SYNTEX PHARMACEUTICAL LTD. (GB) | 1994-01-04 | — | — | US | disclosed |
| US-5252736-A | Calcium channel antagonists | SYNTEX PHARMACEUTICALS, LTD. (GB) | 1993-10-12 | — | — | US | disclosed |
| US-5091428-A | Calcium channel blockers preferential for cerebral blood vessels | SYNTEX PHARMACEUTICALS, LTD. (BM) | 1992-02-25 | — | — | US | disclosed |
| US-5043447-A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives | SYNTEX PHARMACEUTICALS, LTD. (GB) | 1991-08-27 | — | — | US | disclosed |
| US-5010075-A | Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent | SYNTEX PHARMACEUTICALS LTD. (GB) | 1991-04-23 | — | — | US | disclosed |
| US-4935417-A | CALCIUM CHANNEL BLOCKERS | SYNTEX PHARMACEUTICALS LTD. (BM) | 1990-06-19 | — | — | US | disclosed |
| US-4829065-A | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives | SYNTEX PHARMACEUTICALS, LTD. (GB) | 1989-05-09 | — | — | US | disclosed |